Skip to main content
Clinical Trials/NCT06595368
NCT06595368CompletedNot Applicable

A Randomized Controlled Trial Comparing the Efficacy of Vimala Massage Versus Hydrotherapy on Clinical Outcomes in Neonatal Hyperbilirubinemia

Kafrelsheikh University2 sites in 1 country90 target enrollmentStarted: July 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
90
Locations
2
Primary Endpoint
Change from baseline of Total serum bilirubin level on Total serum bilirubin level monitoring sheet

Study Overview

Brief Summary

The aim of this study is to evaluate the effect of Vimala massage versus hydrotherapy on the clinical outcomes of neonatal hyperbilirubinemia.

Detailed Description

The researchers explained the study's aim, benefits, and procedures for participation, after that the parents of the neonates provided an informed consent. Neonatal baseline data was collected from their records on the first day of admission for the three groups prior to intervention in order to identify neonates who meet the required criteria of the study. then the participants were selected and divided randomly (using a simple random method) into three equal groups. One subject for the control group, one for the study group (I), then the other for study group (II), and so on, distributed the participants into three equivalent groups as fellow:

Control Group: Consisted of 30 newborns who will receive conventional hospital care with no additional interventions.

Study Group (I): Consisted of 30 neonates who will receive Vimala massage. The massage will be given three times per day, each lasting 15 minutes and planned one hour after the first feeding of each shift.

Study Group (II): Consisted of 30 neonates who will receive hydrotherapy. It will be applied two times per day before feeding, each lasting 5-10 min.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
37 Weeks to 42 Weeks (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • full-term neonates aged 37- 42 weeks of gestation with a birth weight of ≥1500 g and a five-minute Apgar score of seven or above. Furthermore, the newborn with physiological jaundice will be admitted for phototherapy from the first to the tenth day, and the infant's vital signs will remain normal

Exclusion Criteria

  • major congenital malformations, intestinal obstruction, congenital heart disease, sepsis, neonates with a disease that disrupts skin integrity (epidermolysis bullosa, ichthyosis, collodion baby).

Outcomes

Primary Outcomes

Change from baseline of Total serum bilirubin level on Total serum bilirubin level monitoring sheet

Time Frame: Daily measurement from first day of neonate's admission to day 5 of admission

Total serum bilirubin level monitoring sheet: it includes 2 tests of total serum bilirubin level \& indirect serum bilirubin tests. The daily measurement will be done, its primary purpose is to evaluate the effect of Vimala massage and hydrotherapy on newborns with Jaundice undergoing phototherapy. Bilirubin will be measured using microassay.

Change from baseline of neonate's weight on Bilirubin excretion monitoring sheet

Time Frame: Daily measurement from first day of neonate's admission to day 5 of admission

Bilirubin excretion monitoring sheet: it includes daily measurement of the neonate's weight

Change from baseline of neonate's number of diaper exchange to monitor the frequency of defection and amount of stool on Bilirubin excretion monitoring sheet

Time Frame: Daily measurement from first day of neonate's admission to day 5 of admission

Bilirubin excretion monitoring sheet: it includes daily monitoring of infant's diaper exchange to monitor the frequency of defection and amount of stool

Change from baseline of neonate's total feeding amount on Bilirubin excretion monitoring sheet

Time Frame: Daily measurement from first day of neonate's admission to day 5 of admission

Bilirubin excretion monitoring sheet: it includes daily monitoring of neonate's total feeding amount

Secondary Outcomes

  • Estimate the time of jaundice regression and duration of phototherapy on Clinical efficacy monitoring tool(through 5 days from admission)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Eman Wardany Abdelaal Mohamed

assistant professor of pediatric nursing

Kafrelsheikh University

Study Sites (2)

Loading locations...

Similar Trials